Literature DB >> 16633123

Social stigmatization and hepatitis C virus infection.

Steven Zacks1, Kimberly Beavers, Dickens Theodore, Karen Dougherty, Betty Batey, Jeremy Shumaker, Joseph Galanko, Roshan Shrestha, Michael W Fried.   

Abstract

GOAL: Our aim was to assess stigmatization by evaluating the impact of hepatitis C virus (HCV) on social interactions, feelings of rejection, internalized shame, and financial insecurity, and behavior.
BACKGROUND: HCV patients suffer from slowly progressive disease. Although much research has improved the long-term prognosis of chronic HCV, quality of life may be affected by perceived social stigmatization. STUDY: In a cross-sectional study, HCV patients without cirrhosis or significant comorbidities were recruited from the University of North Carolina viral hepatitis clinic. Subjects completed a questionnaire administered by a trained interviewer that assessed changes in sexual behavior, personal hygiene habits, social function, and interactions. Additionally, subjects completed validated, standardized questionnaires, the Health Status Questionnaire, and the SCL-90-R. Frequencies were calculated for the prevalence of stigmatization and altered social interaction. Correlations between education and behavior changes were assessed. A series of multivariate analyses controlling for age, sex, and education were performed to assess the association between HCV acquisition risk and stigmatization.
RESULTS: One hundred seventy-five of 217 potential subjects (81%) participated in the survey. The average age was 45.2+/-7.7 years. Fifty-five percent were men and 53% were single. Twenty-nine percent had some college education. Risk factors for HCV acquisition included transfusion (21%) and injection drug use (29%), whereas 32% had an unknown mode of infection. Among common activities, 47% were less likely to share drinking glasses, 14% were less likely to prepare food, and one-third of subjects were less likely to share a towel. Thirty-five percent of respondents reported changes in their sexual practices. Decreased frequency of kissing and sexual intercourse was reported in 20% and 27% of individuals, respectively. Almost half of the single subjects reported increased use of condoms compared with only 20% among married couples. The majority of subjects perceived financial insecurity, internalized shame, and social rejection. Only 39% reported health impairment. Education level did not influence behavior change.
CONCLUSION: The majority of HCV subjects alter common behaviors and report financial insecurity, internalized shame, and social rejection, regardless of the method of HCV acquisition or socioeconomic status. These findings indicate that all HCV individuals be counseled and encouraged to participate in educational programs at the time of diagnosis to reduce unnecessary behavioral changes and stigmatization perceptions to improve quality of life.

Entities:  

Mesh:

Year:  2006        PMID: 16633123     DOI: 10.1097/00004836-200603000-00009

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  28 in total

1.  Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.

Authors:  D M Evon; K M Simpson; D Esserman; A Verma; S Smith; M W Fried
Journal:  Aliment Pharmacol Ther       Date:  2010-09-17       Impact factor: 8.171

2.  Health Beliefs and Co-morbidities Associated with Appointment-Keeping Behavior Among HCV and HIV/HCV Patients.

Authors:  Pooja Pundhir; Carol S North; Oluwatomilade Fatunde; Mamta K Jain
Journal:  J Community Health       Date:  2016-02

3.  Kissing: hullo hpv.

Authors:  Louis Z G Touyz
Journal:  Curr Oncol       Date:  2011-08       Impact factor: 3.677

Review 4.  Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?

Authors:  Donna M Evon; Carol E Golin; Michael W Fried; Francis J Keefe
Journal:  J Consult Clin Psychol       Date:  2012-06-25

5.  Knowledge and attitudes of students towards viral hepatitis B and C at the University of Lome.

Authors:  A Bagny; O Bouglouga; M A Djibril; Y L Kaaga; A Dusabe; A L M Lawson; D H Sama; D Redah
Journal:  Indian J Gastroenterol       Date:  2015-01

Review 6.  Barriers to hepatitis C treatment.

Authors:  Christopher E McGowan; Michael W Fried
Journal:  Liver Int       Date:  2012-02       Impact factor: 5.828

Review 7.  Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.

Authors:  Jason E Bonner; A Sidney Barritt; Michael W Fried; Donna M Evon
Journal:  Dig Dis Sci       Date:  2012-04-07       Impact factor: 3.199

8.  A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care.

Authors:  Christopher E McGowan; Ali Monis; Bruce R Bacon; Josep Mallolas; Fernando L Goncales; Ioannis Goulis; Fred Poordad; Nezam Afdhal; Stefan Zeuzem; Teerha Piratvisuth; Patrick Marcellin; Michael W Fried
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

9.  The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life.

Authors:  Jeffrey W Kwan; Ruth C Cronkite; Antony Yiu; Mary K Goldstein; Lewis Kazis; Ramsey C Cheung
Journal:  Qual Life Res       Date:  2008-04-22       Impact factor: 4.147

Review 10.  Controversies in and challenges to our understanding of hepatitis C.

Authors:  Robert G Batey
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.